Golimumab for Psoriatic Arthritis User Reviews (Page 2)
Brand names: Simponi, Simponi Aria
Golimumab has an average rating of 4.6 out of 10 from a total of 28 reviews for the treatment of Psoriatic Arthritis. 29% of reviewers reported a positive experience, while 50% reported a negative experience.
Reviews for Golimumab
- Indydeb
- November 25, 2017
Simponi (golimumab) "It got worse on this"
- Randy
- Taken for 1 to 6 months
- August 10, 2021
Simponi Aria (golimumab) "I had a good results with this medication. It relieved a lot of fatigue I was having. I have a lot less joint pain.My mobility have improved greatly."
Frequently asked questions
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about golimumab
- Check interactions
- Compare alternatives
- Reviews (150)
- Side effects
- Dosage information
- During pregnancy
- Drug class: TNF alfa inhibitors
- Breastfeeding
- En español
Simponi (golimumab) "I received all of the side effects. "